Login / Signup
Lorlatinib in Frontline Therapy for ALK+ Advanced Non-Small-Cell Lung Cancer: Still a Matter of Debate?
Maurice Pérol
Aurélie Swalduz
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
</>
advanced non small cell lung cancer
epidermal growth factor receptor
tyrosine kinase